UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing Fetus

Kansas journal of medicine, 2023-10, Vol.16 (3), p.277-279

2023

Volltextzugriff (PDF)

Illicit Non-Pharmaceutical Fentanyl and Its Analogs: A Short Review of Literature

Kansas journal of medicine, 2023-01, Vol.16 (1), p.25-27

2023

Volltextzugriff (PDF)

Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form

Journal of addictive diseases, 2024-01, p.1-6

2024

Volltextzugriff (PDF)

Tianeptine as an opiate replacement in a patient on methadone treatment: A case report

Journal of opioid management, 2024-01, Vol.20 (1), p.87-91

2024

Volltextzugriff (PDF)

Covid 19 Impact Screening of Patients Undergoing Medication Treatment for Opioid use Disorder

Substance abuse, 2021-04, Vol.42 (2), p.213-219

2021

Volltextzugriff (PDF)

The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the Literature

Primary care companion for CNS disorders, 2023-01, Vol.25 (1)

2023

Volltextzugriff (PDF)

Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: “A case series”

Journal of opioid management, 2021, Vol.17 (7), p.167-170

2021

Volltextzugriff (PDF)

Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder

Primary care companion for CNS disorders, 2022-12, Vol.24 (6)

2022

Volltextzugriff (PDF)

Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphine

The American journal on addictions, 2014-05, Vol.23 (3), p.318-319

2014

Volltextzugriff (PDF)

Phenibut Dependence and Withdrawal

Primary care companion for CNS disorders, 2021-02, Vol.23 (1)

2021

Volltextzugriff (PDF)

Will Adding Methadone to Controlled Substance Monitoring Programs Help Psychiatrists Prevent Prescription Drug Overdoses?

Primary care companion for CNS disorders, 2016, Vol.18 (2)

2016

Volltextzugriff (PDF)

The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review

Primary care companion for CNS disorders, 2023-11, Vol.25 (6)

2023

Volltextzugriff (PDF)

The Appearance of Xylazine in the United States as a Fentanyl Adulterant

Primary care companion for CNS disorders, 2023-10, Vol.25 (6)

2023

Volltextzugriff (PDF)

Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report

Journal of addictive diseases, 2022-07, Vol.40 (3), p.439-443

2022

Volltextzugriff (PDF)

Covid19 impact screening of patients undergoing medication treatment for opioid use disorder

Substance abuse, 2021, Vol.42 (2), p.213-219

2021

Volltextzugriff (PDF)

Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic Instability

Primary care companion for CNS disorders, 2020-09, Vol.22 (5)

2020

Volltextzugriff (PDF)

I Use "Wax" Because It Makes Me Calmer, But Now I Am Seeing 3D Images

Primary care companion for CNS disorders, 2018-06, Vol.20 (3)

2018

Volltextzugriff (PDF)

The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient Setting

Kansas journal of medicine, 2024-03, Vol.17 (1), p.20-21

2024

Volltextzugriff (PDF)

Should Long-Acting Depot Intramuscular Naltrexone Be Prescribed Every 3 Weeks for Alcohol Use Disorder?

Primary care companion for CNS disorders, 2019-05, Vol.21 (3)

2019

Volltextzugriff (PDF)

The Emergence of "Coachella" Heroin in the Midwest

Primary care companion for CNS disorders, 2019-07, Vol.21 (4)

2019

Volltextzugriff (PDF)

Urine toxicology screen negative for Methadone metabolite but positive for Methadone in a patient on Methadone maintenance therapy (MMT)

Asian journal of psychiatry, 2020-04, Vol.50, p.101969, Article 101969

2020

Volltextzugriff (PDF)

I Have Never Used Methamphetamine, But My Urinalysis Says I Do

Primary care companion for CNS disorders, 2018-10, Vol.20 (5)

2018

Volltextzugriff (PDF)

Gabapentin and Buprenorphine Nasal Insufflation in a Patient on Buprenorphine for Opioid Use Disorder

American Journal of Hospital Medicine, 2019-04, Vol.3 (2)

2019

Volltextzugriff (PDF)

Are "bath salts" on your differential list? A case report of delirium and agitation after use of illicit bath salts

Primary care companion for CNS disorders, 2013, Vol.15 (2)

2013

Volltextzugriff (PDF)

Doxazosin for the treatment of nightmares: does it really work? A case report

Primary care companion for CNS disorders, 2012, Vol.14 (5)

2012

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(46)
Berichte
(6)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Male
(10)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Adult
(8)
Case Report
(7)
Opioid-Related Disorders - Drug Therapy
(7)
Letters To The Editor
(6)
Opioid Use Disorder
(6)
Middle Aged
(5)
Opiate Substitution Treatment
(5)
Female
(4)
Medication-Assisted Treatment
(4)
Narcotics - Administration & Dosage
(4)
Substance Abuse
(4)
Buprenorphine
(3)
Buprenorphine - Therapeutic Use
(3)
Naltrexone - Therapeutic Use
(3)
Patients
(3)
Addictions
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing Fetus

Illicit Non-Pharmaceutical Fentanyl and Its Analogs: A Short Review of Literature

Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form

Tianeptine as an opiate replacement in a patient on methadone treatment: A case report

Covid 19 Impact Screening of Patients Undergoing Medication Treatment for Opioid use Disorder

The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the Literature

Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: “A case series”

Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder

Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphine

Phenibut Dependence and Withdrawal

Will Adding Methadone to Controlled Substance Monitoring Programs Help Psychiatrists Prevent Prescription Drug Overdoses?

The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review

The Appearance of Xylazine in the United States as a Fentanyl Adulterant

Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report

Covid19 impact screening of patients undergoing medication treatment for opioid use disorder

Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic Instability

I Use "Wax" Because It Makes Me Calmer, But Now I Am Seeing 3D Images

The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient Setting

Should Long-Acting Depot Intramuscular Naltrexone Be Prescribed Every 3 Weeks for Alcohol Use Disorder?

The Emergence of "Coachella" Heroin in the Midwest

Urine toxicology screen negative for Methadone metabolite but positive for Methadone in a patient on Methadone maintenance therapy (MMT)

I Have Never Used Methamphetamine, But My Urinalysis Says I Do

Gabapentin and Buprenorphine Nasal Insufflation in a Patient on Buprenorphine for Opioid Use Disorder

Are "bath salts" on your differential list? A case report of delirium and agitation after use of illicit bath salts

Doxazosin for the treatment of nightmares: does it really work? A case report

Suchergebnisse filtern